ARK Invest · holdings as of 2026-10-14

ARKQ

ARK Autonomous Technology & Robotics ETF

Last / close
$115.84
Day change
-$4.27 · -3.56%
Volume
Not reported
NAV
Not reported
Premium / discount
Not reported
Live · updated 15:27:55 ET · As of Oct 14, 2026, 3:27 PM EDTMarket quote receipt →

Autonomous mobility, robotics, energy storage, space, and enabling technology from ARK's complete daily holdings file.

Veridion read
47Middle range · medium confidence
Fund score · valuation-exempt

4/5 applicable factors · 2026-10-13 · methodology receipt

Published holdings
37
Primary source
Issuer fund page →
01

Fund observations

Market and fund figures, each dated to its source.

A blank cell means the field does not have a qualified source. Price-derived AUM change is never relabeled as fund flow.

Expense ratio
0.75%
2026-03-31
Inception
2014-09-30
2026-03-31
Holdings
37
2026-10-14
YTD return
+1.41%
2026-10-13
1Y return
-0.51%
2026-10-13

Every weight here comes straight from the issuer's filing — not our estimate.

02

Complete issuer book

All 37 holdings

Every row resolves to the issuer file dated 2026-10-14. Paid overlays add Scores and historical weight changes without altering the public holdings structure.

Public disclosures

Congress activity in ARKQ

No receipt-qualified filings found.

03

Comparative read

Weight-adjusted Score and shared-book overlap.

The fund Score is a weighted aggregation of covered holdings, not a separately trained ETF model. Overlap uses only published issuer books.

01AIQ22.70%10 shared holdings
02SMH18.73%6 shared holdings
03SOXX18.66%5 shared holdings
04XLK16.22%7 shared holdings
05BOTZ15.76%10 shared holdings
06XAR15.35%7 shared holdings
07CHAT15.24%4 shared holdings
08ARTY14.19%4 shared holdings

Coverage note. AUM, Net flows, AUM change are not reported with a qualified receipt; 37 holding quotes are unresolved; 1 issuer row has no tradable ticker; the Score and ownership-change overlays are withheld from the free response. Open the issuer holdings receipt →

Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.